의지 및 보조기 시장 : 제품별, 사용 소재별, 환자 유형별, 기술별, 최종 사용자별, 용도별, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Prosthetics & Orthotics Market is projected to grow by USD 11.50 billion at a CAGR of 5.62% by 2032.

The prosthetics and orthotics market is moving from device replacement toward data-enabled mobility, rehabilitation, and lifelong functional care. Demand is anchored in verified public health drivers: the World Health Organization estimates that 2.4 billion people need rehabilitation services, while WHO and the International Society for Prosthetics and Orthotics have reported that 35-40 million people require prosthetic and orthotic services globally, with access in many low- and middle-income countries remaining limited.

Demand is further supported by population aging, diabetes-related limb loss, trauma, vascular disease, sports injuries, stroke, spinal conditions, and congenital limb differences. The International Diabetes Federation reported 537 million adults living with diabetes in 2021 and projects 643 million by 2030, increasing the need for limb preservation, diabetic foot orthoses, lower-limb prosthetics, custom bracing, and structured prosthetic rehabilitation pathways.

Transformative Shifts in the Prosthetics & Orthotics Landscape

The prosthetics and orthotics landscape is being reshaped by patient-specific fabrication, digital scanning, CAD/CAM workflows, 3D printing, lightweight carbon fiber, microprocessor knees, myoelectric hands, sensor-enabled foot systems, spinal orthoses, and integrated rehabilitation software. These shifts are improving comfort, alignment, gait efficiency, socket fit, clinical documentation, and continuity of care while compressing design-to-delivery cycles.

At the same time, reimbursement scrutiny, outcomes-based procurement, clinician workforce shortages, and supply chain resilience are changing competitive priorities. Industry leaders are increasingly judged not only on component performance but also on fit accuracy, service continuity, evidence generation, repairability, regulatory compliance, and the ability to support multidisciplinary care across hospitals, specialty clinics, community rehabilitation centers, and home-based rehabilitation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accumulating impact across prosthetic and orthotic design, assessment, training, and follow-up care. AI-assisted gait analysis, pressure mapping, image-based limb shape capture, and predictive socket-fit models can help clinicians personalize devices and identify alignment or comfort problems earlier. Machine learning also supports pattern recognition in myoelectric control, enabling more intuitive prosthetic hand use when validated in real-world clinical conditions.

The commercial value of AI will depend on clinical governance and evidence quality. FDA, MDR, HIPAA, GDPR, and equivalent data protection frameworks require transparent validation, cybersecurity, bias monitoring, human oversight, and traceable decision support. The strongest opportunities are in clinician-augmented workflows that improve prosthetic fitting, orthotic design, rehabilitation monitoring, and patient adherence rather than fully automated care decisions.

Key Regional Insights

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in rehabilitation capacity, local manufacturing, assistive technology access, and digital health adoption. The region's demand is shaped by diabetes prevalence, road traffic injuries, stroke-related mobility impairment, aging populations, and government initiatives supporting disability inclusion. North America remains a premium innovation hub supported by advanced clinical networks, veterans' rehabilitation, private and public insurance pathways, FDA-regulated technology adoption, and strong demand for microprocessor knees, myoelectric prosthetics, custom orthotics, and sports rehabilitation devices.

Europe benefits from structured reimbursement, MDR oversight, established rehabilitation systems, and strong clinical evidence standards, supporting adoption of advanced prosthetic and orthotic technologies across hospital and outpatient settings. Latin America is improving access through public health procurement, private specialty clinics, and expanding orthopedic and rehabilitation services, with Mexico and Brazil driving demand linked to diabetes, trauma, and musculoskeletal conditions. The Middle East is investing in tertiary rehabilitation, trauma care, and advanced mobility solutions, particularly in GCC economies. Africa presents one of the largest access gaps, where WHO-documented unmet rehabilitation need makes affordability, workforce development, local assembly, donation governance, and distributed service models critical for improving prosthetics and orthotics access.

Key Group Insights

ASEAN markets are gaining momentum through expanding hospital networks, medical tourism, rehabilitation services, and government disability inclusion programs, with demand supported by diabetes, road traffic injuries, and occupational injuries. The GCC is characterized by high healthcare spending, imported premium components, expanding rehabilitation centers, and investment in advanced trauma and mobility care. The European Union emphasizes patient safety, clinical evidence, procurement transparency, post-market surveillance, and MDR compliance, making documentation quality and regulatory readiness central to prosthetic and orthotic adoption.

BRICS economies combine large patient populations with industrial localization priorities, creating demand for cost-effective prosthetic and orthotic systems, domestic production, and scalable clinical training. G7 countries lead in reimbursement sophistication, advanced robotics, sensor-enabled devices, rehabilitation research, and outcomes measurement. NATO members also sustain demand through military rehabilitation, veteran services, amputee mobility programs, and trauma recovery pathways that support innovation in high-performance prosthetics, orthotics, and assistive rehabilitation technologies.

Key Country Insights

The United States leads in advanced prosthetic components, clinical specialization, digital fitting workflows, and veterans' rehabilitation, while Canada emphasizes publicly supported care pathways, provincial reimbursement structures, and equitable access across urban and rural settings. Mexico and Brazil combine rising diabetes burden with expanding private and public orthopedic care, increasing the need for lower-limb prosthetics, diabetic foot orthoses, fracture bracing, and rehabilitation services. The United Kingdom, Germany, France, Italy, and Spain benefit from established rehabilitation ecosystems, national health systems, and clinical standards, while Germany remains a major engineering and manufacturing center for precision prosthetic and orthotic technologies.

Russia requires durable, accessible solutions across a broad geography where service continuity and regional distribution are important. China and India are high-volume markets shaped by diabetes, trauma, stroke rehabilitation, localization, public health capacity, and affordability. Japan and South Korea emphasize robotics, aging-related mobility, precision manufacturing, and technology-enabled rehabilitation, supporting adoption of advanced prosthetic knees, upper-limb systems, and orthotic devices. Australia supports advanced rehabilitation across urban clinical networks while addressing service delivery challenges in remote and Indigenous communities through telehealth, mobile clinics, and distributed care models.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed outcomes, faster fitting workflows, and affordability without compromising safety, comfort, or durability. Investment in digital scanning, CAD/CAM, modular components, 3D printing, remote follow-up, pressure monitoring, and repair networks can improve patient retention, reduce lifecycle cost, and support better clinical documentation.

Organizations should build partnerships with rehabilitation hospitals, diabetes clinics, vascular surgeons, orthopedic specialists, payers, veteran programs, public procurement agencies, universities, and disability inclusion organizations. Stronger clinical education, prosthetist and orthotist training, technician development, cybersecurity controls, usability testing, and post-market surveillance will be essential to scale AI-enabled and sensor-based prosthetic and orthotic devices responsibly.

Research Methodology

The research methodology applies a mixed-method approach combining verified secondary sources, primary interviews, and structured triangulation. Sources include WHO, ISPO, International Diabetes Federation, OECD, World Bank, national health agencies, regulatory databases, reimbursement references, procurement records, clinical literature, standards bodies, patent activity, and public disclosures relevant to prosthetics, orthotics, rehabilitation, and assistive technology.

Primary validation is conducted through discussions with manufacturers, prosthetists, orthotists, rehabilitation specialists, distributors, payers, procurement stakeholders, clinicians, and assistive technology experts. Findings are cross-checked through demand driver mapping, regulatory assessment, clinical pathway analysis, technology benchmarking, regional access evaluation, and expert review to ensure reliability, traceability, and practical relevance without relying on unsupported estimates.

Conclusion

The prosthetics and orthotics industry is entering a new phase defined by personalized mobility, digital care pathways, and measurable rehabilitation outcomes. Long-term demand is supported by aging populations, diabetes prevalence, trauma, vascular disease, musculoskeletal disorders, and a large unmet need for rehabilitation services and assistive technology worldwide.

Organizations that combine clinically validated technology with accessible service models will be best positioned to lead. The next competitive frontier will favor providers and manufacturers that integrate human expertise, AI-assisted design, regional adaptability, regulatory discipline, and strong evidence generation into scalable prosthetic and orthotic care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Prosthetics & Orthotics Market, by Product

• 7.1. Orthotics
  • 7.1.1. Lower limb
  • 7.1.2. Spinal
  • 7.1.3. Upper limb
• 7.2. Prosthetics
  • 7.2.1. Facial Prosthetics
  • 7.2.2. Lower Extremity Prosthetics
  • 7.2.3. Upper Extremity Prosthetics

8. Prosthetics & Orthotics Market, by Material Used

• 8.1. Carbon Fiber
• 8.2. Foam-Based
• 8.3. Metal
• 8.4. Plastic-Based
• 8.5. Silicone-Based

9. Prosthetics & Orthotics Market, by Patient Type

• 9.1. Adult Patients
• 9.2. Geriatric Patients
• 9.3. Pediatric Patients

10. Prosthetics & Orthotics Market, by Technology

• 10.1. Conventional
• 10.2. Powered

11. Prosthetics & Orthotics Market, by End User

• 11.1. Home Care Settings
• 11.2. Hospitals & Clinics
• 11.3. Orthotic & Prosthetic Clinics
• 11.4. Rehabilitation Centers

12. Prosthetics & Orthotics Market, by Application

• 12.1. Congenital Conditions
• 12.2. Degenerative Diseases
• 12.3. Neurological Conditions
• 12.4. Sports Injuries
• 12.5. Trauma

13. Prosthetics & Orthotics Market, by Distribution Channel

• 13.1. Offline
• 13.2. Online

14. Prosthetics & Orthotics Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Prosthetics & Orthotics Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Prosthetics & Orthotics Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. B.Braun SE
• 18.2. Bauerfeind AG
• 18.3. Beast Prosthetics
• 18.4. Beijing Jingbo modern prosthetics and orthotics Technology Co. Ltd.
• 18.5. Bionic Prosthetics & Orthotics Group LLC
• 18.6. Blatchford Limited
• 18.7. Boston Scientific Corporation
• 18.8. CHENG CHUAN PROSTHETICS & ORTHOTICS CO., LTD.
• 18.9. COAPT LLC.
• 18.10. COVVI Ltd
• 18.11. Globus Medical Inc.
• 18.12. Hanger, Inc.
• 18.13. Howard Orthopedics, Inc.
• 18.14. Human Technology, Inc.
• 18.15. Johnson & Johnson Services, Inc.
• 18.16. Ktwo Healthcare Pvt. Ltd
• 18.17. Merck & Co, Inc.
• 18.18. Nabtesco Corporation
• 18.19. Nippon Sigmax Co., Ltd.
• 18.20. Olympus Corporation
• 18.21. Ortho Europe
• 18.22. OrthoPediatrics Corp.
• 18.23. Ossur HF
• 18.24. Ottobock SE & Co. KGaA
• 18.25. REH4MAT sp. z o.o.
• 18.26. Shadow Robot Company
• 18.27. Shapeways Holdings, Inc.
• 18.28. Shijiazhuang Perfect Prosthetic Manufacture Co., Ltd.
• 18.29. Smith & Nephew PLC
• 18.30. Steeper Inc.
• 18.31. Stryker Corporation
• 18.32. Synergy Prosthetics, Inc.
• 18.33. Ultraflex Systems, Inc.
• 18.34. UNYQ DESIGN EUROPE, S.L.
• 18.35. Wacker Chemie AG
• 18.36. WillowWood Global LLC
• 18.37. Zimmer Biomet Holdings, Inc.